BMY
78
2
LEN
21
-9
ACN
54
-2
SYK
35
4
URI
49
3
KLAC
75
3
DOV
63
-6
CMCSA
50
6
DLTR
58
-5
FSLR
78
5
PVH
30
-2
DVA
51
2
EA
44
-3
GD
64
2
KO
46
2
ORCL
37
4
OI
58
11
KMI
63
10
EXR
26
2
VRSK
32
2
BMY
78
2
LEN
21
-9
ACN
54
-2
SYK
35
4
URI
49
3
KLAC
75
3
DOV
63
-6
CMCSA
50
6
DLTR
58
-5
FSLR
78
5
PVH
30
-2
DVA
51
2
EA
44
-3
GD
64
2
KO
46
2
ORCL
37
4
OI
58
11
KMI
63
10
EXR
26
2
VRSK
32
2
Financhill
Back

STF Tactical Growth & Income ETF Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison

Sell
41

TUGN
STF Tactical Growth & Income ETF

Last Price:
$25.84
Seasonality Move:
-1.93%
Sell
42

SRPT
Sarepta Therapeutics, Inc.

Last Price:
$22.01
Seasonality Move:
10.38%
Sell
41
STF Tactical Growth & Income ETF (TUGN) is a Sell

Is STF Tactical Growth & Income ETF a Buy, Sell or Hold?

  • The current STF Tactical Growth & Income ETF [TUGN] share price is $25.66. The Score for TUGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • TUGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Sarepta Therapeutics, Inc. (SRPT) is a Sell

Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.23. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TUGN Stock Price Chart

What is STF Tactical Growth & Income ETF's stock price today?

  • The STF Tactical Growth & Income ETF share price today is $25.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TUGN is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics, Inc.'s stock price today?

  • The Sarepta Therapeutics, Inc. share price today is $21.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.

TUGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.67 Buy
Relative Strength Index (14 RSI): 49.24 Sell
Chaikin Money Flow: -3150 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.29 - 25.89) Buy
Bollinger Bands (100): (25.15 - 26.25) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.67 Buy
Relative Strength Index (14 RSI): 52.08 Buy
Chaikin Money Flow: 241834 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.51 - 22.31) Buy
Bollinger Bands (100): (17.63 - 22.21) Buy

TUGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.5 Buy
20-day SMA: 25.67 Sell
50-day SMA: 25.91 Sell
200-day SMA: 24.32 Buy
8-day EMA: 16.16 Buy
20-day EMA: 8.4 Buy
50-day EMA: 3.76 Buy
200-day EMA: 1 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.36 Sell
20-day SMA: 21.24 Sell
50-day SMA: 20.76 Buy
200-day SMA: 31.65 Sell
8-day EMA: 13.3 Buy
20-day EMA: 6.91 Buy
50-day EMA: 3.1 Buy
200-day EMA: 0.82 Buy

STF Tactical Growth & Income ETF Earnings Growth & TUGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.

STF Tactical Growth & Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):